dalpiciclib
jiangsu hengrui pharmaceuticals
['breast', 'vance', 'dalpiciclib', 'bcsm']
first-line dalpiciclib significantly improves pfs outcomes for patients with hr+/her2 advanced breast cancer #bcsm #esmo2022 
Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.